UTICA, N.Y. — ConMed Corp. (NYSE: CNMD) on Tuesday reduced the first-quarter revenue expectations for its global business, based on the current status of the spread of the coronavirus.
The firm now expects organic constant currency revenue growth for the first quarter of 2020 to range between 2 percent and 4 percent. That’s compared to the previous range of 5 to 6 percent that management discussed during its fourth quarter and full-year 2019 earnings conference call.
ConMed noted it does expect a “favorable” adjustment in the anticipated first quarter 2020 effective tax rate to help offset the financial impact of COVID-19, the formal name of the coronavirus.
(Sponsored)
Maximizing Tax Benefits for Energy-Efficient Buildings
The Inflation Reduction Act (IRA) of 2022 significantly enhanced the Section 179D deduction, making it even more valuable for businesses investing in energy-efficient commercial building property (EECBP) and energy-efficient commercial
How CH Insurance’s BOOST Program Optimizes Group Benefits for Small Businesses
For small business owners, navigating the complexities of group benefits can be overwhelming. Between compliance regulations, cost considerations, and employee expectations, offering a competitive benefits package often feels like a
As a result, management now anticipates that the company’s first quarter adjusted diluted net earnings per share growth rate will be in the mid-single digits compared to the previously provided guidance range of high-single digit to low-double digit growth.
As of now, ConMed isn’t updating its full-year 2020 guidance. The surgical-device maker will provide an update on its full-year guidance as part of the first quarter 2020 earnings release.
Utica–based ConMed is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The firm’s products are used by surgeons and physicians in specialties that include orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
Contact Reinhardt at ereinhardt@cnybj.com
